Journal article icon

Journal article

CTAS - A CT score to quantify disease activity in pulmonary sarcoidosis

Abstract:

Background

A major gap in the management of sarcoidosis is the lack of accessible and objective methods to measure disease activity. Since 90% of patients have pulmonary involvement, we explored if a disease activity score based on thoracic CT scans could address this clinical issue.

Methods

High resolution CT scans from 100 consecutive sarcoidosis patients at a regional sarcoidosis service were scored for extent of CT abnormalities known to relate to granuloma or lymphocytic infiltration from published CT-pathological studies. These individual abnormality scores were then correlated against serum ACE, sIL-2R and change in forced vital capacity (FVC) to identify CT abnormalities that reflect contemporaneous disease activity. The sum of these scores, or CT Activity Score (CTAS) was then validated against FVC response to treatment.

Findings

CT extent scores for nodularity, ground-glass opacification, inter-lobular septal thickening and consolidation correlated significantly with at least one of the disease activity parameters and were used to form CTAS. CTAS was found to predict FVC response to treatment at one year and was highly reproducible between radiologists. An abbreviated CTAS (aCTAS), constructed from presence or absence of the four CT abnormalities also showed significant correlation with FVC response to treatment. CTAS and aCTAS also correlated with response to treatment in the fibrotic subgroup.

Interpretation

CTAS provides a concept for an objective and reproducible CT scoring method to quantify disease activity in sarcoidosis. The score can potentially be used to stratify patients according to disease activity, determine response to treatment and establish if fibrotic sarcoidosis is active.

Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1136/thoraxjnl-2016-208833

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
NDM Experimental Medicine
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
NDM Experimental Medicine
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
RDM
Sub department:
Weatherall Insti. of Molecular Medicine
Role:
Author
More by this author
Institution:
University of Oxford
Oxford college:
Pembroke College
Role:
Author


Publisher:
BMJ Publishing Group
Journal:
Thorax More from this journal
Volume:
71
Pages:
1161-1163
Publication date:
2016-07-01
Acceptance date:
2016-07-27
DOI:
ISSN:
1468-3296


Keywords:
Pubs id:
pubs:631837
UUID:
uuid:cad878b2-6ee6-4b75-9e86-9e8d8e6273b1
Local pid:
pubs:631837
Source identifiers:
631837
Deposit date:
2016-07-05
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP